Asimenia Angelidou to Immunogenicity, Vaccine
This is a "connection" page, showing publications Asimenia Angelidou has written about Immunogenicity, Vaccine.
Connection Strength
0.687
-
Angelidou A, Conti MG, Diray-Arce J, Benn CS, Shann F, Netea MG, Liu M, Potluri LP, Sanchez-Schmitz G, Husson R, Ozonoff A, Kampmann B, van Haren SD, Levy O. Licensed Bacille Calmette-Gu?rin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. Vaccine. 2020 02 24; 38(9):2229-2240.
Score: 0.631
-
Amodio D, Angelidou A, Cotugno N, Sherman AC, Levy O, Palma P. Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference. Vaccine. 2025 01 01; 43(Pt 2):126477.
Score: 0.055